19 Mar
Potentially Reduce Major Adverse Cardiovascular Events
AMR Dearborn is currently conducting a clinical study of an investigational medication to potentially reduce major cardiovascular events.
Qualified participants must:
be ages 18 and older with a history of a major cardiovascular event Or
be ages 50 and older who are at high risk for having their first major cardiovascular event
meet other study criteria
Qualified participants will receive:
all study-related care and the investigational medication or placebo at no cost
compensation up to $2,550.00 for time and travel
Learn more by calling AMR Dearborn at 313-887-4365 or by visiting www.amrdearborn.com today!